How Is Myasthenia Gravis Diagnosed? Tests, Results, and Next Steps

Myasthenia gravis (MG) is diagnosed by combining a person's symptoms and neurological examination with tests that look for problems at the neuromuscular junction. These can include antibody blood tests, repetitive nerve stimulation, single-fibre electromyography (SFEMG), and chest imaging. [1,2]

There is no single test that provides the complete answer in every case. Some people have characteristic MG symptoms but negative standard antibody tests. Others have symptoms mainly affecting the eyes, which can make the diagnostic process less straightforward. [2,3]

Experiences shared through mama health also show another side of diagnosis: the uncertainty of having symptoms that change throughout the day, the difficulty of explaining weakness during a “good” appointment, and the relief some people describe when their experiences finally have an explanation.

TL;DR

• MG diagnosis usually combines a neurological assessment with antibody blood tests and, when needed, electrical tests of nerve-to-muscle communication.
• AChR antibodies are found more often in generalised MG than in MG limited to the eyes, so a negative blood test does not automatically rule MG out. [2]
• If AChR antibodies are not detected, additional testing may include MuSK antibodies, specialist neurophysiology, and in selected situations other antibody tests. [3]
• Qualitative experiences shared through mama health highlight how fluctuating symptoms and uncertain test results can make the diagnostic journey difficult to explain and navigate.
• Severe or worsening breathing or swallowing difficulties require urgent medical attention. NHS guidance advises calling 999 in this situation. [4]

How do doctors diagnose myasthenia gravis?

Doctors diagnose MG by looking for a characteristic pattern of muscle weakness and then using laboratory and neurophysiological tests to support or clarify the diagnosis.

The process often begins with a detailed discussion about symptoms. A healthcare professional may ask:

• Which muscles feel weak?
• Does the weakness change during the day?
• Does repeated activity make it more noticeable?
• Does rest make a difference?
• Are the eyes, face, speech, chewing, swallowing, neck, arms or legs affected?
• Have symptoms changed over time?

MG affects communication between nerves and muscles. This is why clinicians are interested in fatigable weakness: weakness that can become more noticeable after repeated muscle use. [1,2]

If you are still trying to understand whether your experiences resemble common features of MG, see mama health's guide to how symptoms can appear and change in myasthenia gravis.

Why can myasthenia gravis be difficult to diagnose?

MG can be difficult to diagnose because its symptoms can fluctuate and overlap with other conditions.

Drooping eyelids, double vision, changes in speech, swallowing difficulties, neck weakness or limb weakness can have several possible causes. A person may also look or feel different at different times of the day.

This variability matters.

Someone may experience obvious eyelid drooping in the evening but have little visible ptosis during a morning appointment. Speech may become more difficult after prolonged talking but sound normal after rest. Limb weakness may also vary depending on activity.

What do people living with MG share about this stage?

Qualitative experiences shared with mama health repeatedly highlight the difficulty of putting fluctuating weakness into words.

Some people describe knowing that something had changed while finding it difficult to demonstrate those symptoms during an appointment. Others describe early conversations focusing on fatigue, stress or another possible explanation before the pattern of muscle weakness was recognised.

Another recurring theme is self-doubt during the diagnostic process. When a symptom appears and disappears, people can find themselves questioning whether they explained it clearly enough or whether it was significant.

These experiences are qualitative. They do not show how common a particular diagnostic pathway is and should not be interpreted as clinical evidence.

They do show why the lived experience of MG can be different from a simple list of diagnostic tests.

Who usually confirms a myasthenia gravis diagnosis?

A neurologist usually leads the specialist assessment for suspected MG.

The route to neurology can differ.

A GP may make a referral after hearing about fluctuating muscle weakness. An optometrist or ophthalmologist may notice unexplained ptosis or double vision. Other people may first reach hospital services because swallowing, speech or breathing has become affected.

The neurological assessment helps bring the different pieces together: symptoms, examination findings, antibody results, neurophysiology and other tests.

Which blood tests are used for myasthenia gravis?

Blood tests for MG look for antibodies associated with disruption of the neuromuscular junction.

The main antibodies considered are:

• acetylcholine receptor antibodies, or AChR antibodies
• muscle-specific kinase antibodies, or MuSK antibodies
• in selected circumstances, low-density lipoprotein receptor-related protein 4 antibodies, or LRP4 antibodies

Antibody results always need to be considered alongside symptoms and examination findings. [2,3]

For more detail, read mama health's guide to the different antibody findings that can occur in MG.

What does an AChR antibody test mean?

A positive AChR antibody result strongly supports an MG diagnosis when the clinical features are compatible with the condition.

AChR antibodies are detectable in around 80–85% of people with generalised MG. They are less often detectable when weakness remains limited to the eye muscles, with estimates around 50% or slightly higher depending on the test and study. [2]

This difference is important because it means a normal AChR antibody test cannot automatically exclude ocular MG.

Antibody concentrations also do not provide a simple measurement of how severe MG is for an individual. A healthcare professional interprets the result alongside the clinical picture.

What happens if AChR antibodies are negative?

If AChR antibodies are not detected but MG remains a clinical possibility, further assessment may be considered.

This can include testing for MuSK antibodies. Depending on the circumstances and specialist laboratory availability, other antibody testing may also be considered. [3]

Some people with clinical and neurophysiological evidence consistent with MG do not have the standard antibodies detected. The term seronegative myasthenia gravis is used in this context. [3]

A negative blood result therefore does not mean that a person's symptoms are unimportant.

It also does not automatically mean the person has MG. Other conditions can cause similar symptoms, so specialist assessment remains essential.

What is the experience of receiving a negative result?

This is one area where collective experience can add useful context.

Experiences shared with mama health describe the uncertainty that can follow a negative antibody result when symptoms are still affecting everyday life.

For some, the difficult part is not simply receiving a negative result. It is understanding what that result does — and does not — mean.

Shared experiences can help show that diagnostic journeys are not always linear. They cannot interpret an individual's laboratory result, but they can help people feel less alone in the uncertainty and give them ideas for questions they may want to discuss with their healthcare team.

What is repetitive nerve stimulation?

Repetitive nerve stimulation is an electrical test that examines how well signals travel from a nerve to a muscle.

Small electrical impulses stimulate a nerve several times while equipment records the muscle's response.

In MG, repeated stimulation can reveal a decrement, meaning that the electrical muscle response becomes smaller with repeated stimulation. This can provide evidence of impaired neuromuscular transmission. [2]

However, repetitive nerve stimulation is not abnormal in every person with MG. The muscles selected for testing and the distribution of weakness can influence the result.

A normal result therefore needs to be interpreted within the wider clinical assessment.

What is single-fibre EMG?

Single-fibre electromyography, or SFEMG, is a sensitive test for detecting abnormal neuromuscular transmission.

The test uses a fine electrode to examine very small variations in the timing of muscle-fibre activation. This variation is called jitter.

Increased jitter can provide evidence that communication between nerves and muscles is not functioning normally. SFEMG can be particularly useful when standard antibody testing has not provided a clear answer. [2,3]

However, an abnormal SFEMG result is not specific to MG. Other neuromuscular conditions can also affect jitter.

This is another reason diagnosis cannot be based on one test alone.

What might electrical testing feel like?

Experiences of neurophysiology vary.

The tests involve electrical stimulation and, for some forms of EMG, a fine needle electrode. Some people describe them as uncomfortable. Others focus more on the uncertainty of waiting to find out what the test shows.

Qualitative experiences shared with mama health suggest that reaching this stage can also feel significant because the investigation is now focusing specifically on nerve-to-muscle communication.

Individual experiences will vary.

Can an ice pack test help identify ocular MG?

An ice pack test can provide an additional clinical clue when someone has a drooping eyelid that may be related to MG.

During the test, cooling is applied briefly to the closed eyelid. A clinician then checks whether the ptosis improves. Cooling can temporarily improve neuromuscular transmission in MG. [2,5]

The ice pack test is most relevant when ptosis is present. It does not establish an MG diagnosis on its own, and studies have reported different levels of diagnostic accuracy.

If weakness mainly involves the eyes, you can also read mama health's guide to MG that affects eye movement and eyelid control.

Is the edrophonium or Tensilon test still used?

The edrophonium test is now rarely used.

Edrophonium temporarily increases the amount of acetylcholine available at the neuromuscular junction. Historically, clinicians looked for a rapid temporary improvement in muscle strength after giving the medicine.

The NHS notes that the test is rarely performed because it can cause potentially serious side effects, including effects on heart rate and breathing. When used, it requires an appropriate hospital setting. [1]

Blood tests and modern neurophysiological investigations have reduced its role in current diagnostic practice.

Why might someone have a CT or MRI scan of the chest?

Chest imaging is used to examine the thymus gland because MG has an important association with thymus abnormalities.

A CT scan or sometimes an MRI can help identify changes such as a thymoma, a tumour of the thymus gland. [1]

The scan does not diagnose MG itself. Instead, it provides information that can be relevant after MG has been identified or when clinicians are completing the assessment.

The relationship between MG and the thymus is complex. You can explore it further in mama health's guide to how the thymus is connected with myasthenia gravis.

Can you have myasthenia gravis with negative tests?

Yes. Standard antibody tests can be negative in someone who ultimately has MG.

This is particularly relevant in ocular MG and seronegative MG. [2,3]

Neurophysiological testing can therefore become more important when antibodies are not detected.

At the same time, a negative antibody result does not prove MG either.

Specialists may consider other explanations for fluctuating weakness, ptosis, double vision, speech changes or swallowing problems. Depending on the situation, additional neurological, eye, blood or imaging investigations may be appropriate.

The diagnosis depends on how all of the available information fits together.

What do test results mean when they do not agree?

Different MG tests answer different questions, so results do not always line up neatly.

For example:

• a person may have characteristic symptoms and positive AChR antibodies;
• someone else may have characteristic symptoms but negative AChR antibodies;
• repetitive nerve stimulation may be normal while another neurophysiological test provides useful information;
• an abnormal electrical test may still require investigation for other possible neuromuscular causes.

This is why results should not be interpreted as isolated “positive means MG” or “negative means no MG” answers.

Clinical context matters.

A neurologist can consider how the history, examination, antibody findings, neurophysiology and imaging fit together.

Why can the diagnostic process feel so uncertain?

The diagnostic process can feel uncertain because the medical investigation and the lived experience do not always move at the same pace.

A test result is a snapshot. MG symptoms can fluctuate.

Qualitative experiences shared through mama health highlight several recurring themes:

• difficulty describing weakness that changes from hour to hour;
• frustration when visible symptoms are absent during an appointment;
• uncertainty after a blood test does not provide a clear answer;
• feeling misunderstood when symptoms initially appear to have another explanation;
• relief when the pattern of fatigable weakness is recognised;
• wanting to know what questions other people found useful during specialist appointments.

These are shared experiences rather than medical findings. They cannot establish whether someone has MG or predict what an individual diagnostic journey will look like.

But they can offer something clinical tests cannot: the collective experience of what it can feel like to move through uncertainty.

How can mama health app help?

mama health provides a space where people living with chronic conditions can learn from educational information and experiences shared by others.

For someone going through an MG assessment, this can provide context around questions such as:

How have other people described fluctuating weakness?

Did other people find it difficult to explain symptoms that were not visible during an appointment?

What questions did others find useful when speaking with a neurologist?

How did others organise their experiences before an appointment?

Seeing these shared experiences can help someone find language for their own journey and feel less isolated.

What could you record before a medical appointment?

Recording when and how symptoms occur can make it easier to explain a fluctuating experience during an appointment.

Information someone may choose to record includes:

• when weakness appears;
• which muscles seem affected;
• whether symptoms change during the day;
• what they were doing before the symptoms became noticeable;
• whether rest appeared to change the experience;
• whether speech, chewing, swallowing, vision or movement felt different;
• questions they want to remember during their next appointment.

Someone with a visible symptom such as eyelid drooping may also choose to keep a photograph or short video for their own records.

This information is for personal reflection and discussion with a healthcare professional. A symptom diary, photograph, video or app cannot diagnose MG.

What happens after myasthenia gravis is diagnosed?

After MG is confirmed, the healthcare team usually builds a clearer picture of how the condition is affecting the individual.

This can include considering:

• whether weakness is ocular or generalised;
• which antibodies are present;
• whether the thymus shows any relevant changes;
• which muscle groups are affected;
• how symptoms affect everyday activities;
• other health conditions and medicines.

These factors can influence subsequent conversations about care.

Management options can include medicines that improve communication between nerves and muscles, medicines that affect immune activity, and thymectomy in selected situations. The most appropriate approach depends on the individual's circumstances and should be discussed with the treating healthcare team. [6]

For educational background, see mama health's overview of medicines that may be discussed in MG care.

Some medicines can also worsen MG or require additional caution. mama health has a separate resource on medicines that may need additional consideration when living with MG.

What questions could you discuss at your next appointment?

Useful questions depend on where someone is in the diagnostic process.

Examples include:

• What findings make MG more or less likely in my situation?
• Which antibody tests have been performed?
• What does my antibody result mean?
• If my AChR antibody test was negative, are other tests relevant?
• Would repetitive nerve stimulation or single-fibre EMG provide useful information?
• Could another condition explain my symptoms?
• Are my symptoms currently considered ocular or generalised?
• Is chest imaging relevant in my situation?
• What did my thymus imaging show?
• Are there medicines I need to mention to other healthcare professionals?
• Which changes in symptoms would require urgent medical attention?
• What happens next in the assessment or follow-up process?

These are examples of questions for discussion. They are not recommendations that a particular test or treatment is necessary.

When do breathing or swallowing problems need urgent help?

Severe or worsening breathing or swallowing difficulties can require emergency medical care.

MG can affect the muscles involved in swallowing and breathing. A severe deterioration affecting breathing can occur during a myasthenic crisis.

NHS guidance advises calling 999 when someone with MG develops severe breathing or swallowing difficulties that are getting worse. [4]

If swallowing is part of your experience, mama health also has educational information about how swallowing difficulties can occur with MG.

What is most important to remember about an MG diagnosis?

An MG diagnosis is built from a pattern of evidence rather than a single universal test.

The clinical history matters. The neurological examination matters. Antibody tests can provide strong evidence, but negative antibodies do not automatically exclude MG. Neurophysiological testing can provide additional information, particularly when the diagnosis remains uncertain. Chest imaging serves a different purpose by assessing the thymus. [1–3]

The lived experience matters too.

For people whose symptoms fluctuate, being able to describe what happens outside the consultation room can be an important part of communicating their experience. Collective stories shared through mama health show that uncertainty, changing symptoms and difficulty explaining weakness are experiences others recognise.

Those shared experiences cannot provide a diagnosis.

They can provide context, useful language and the knowledge that someone else has navigated similar questions.

This content is informational and not a medical device.

mama health offers information and support and does not replace a doctor.

‍

1. NHS. Myasthenia gravis – Diagnosis. Covers blood testing, nerve and muscle testing, chest imaging and the limited contemporary role of edrophonium.

2. Keesey JC, et al. / review literature. Diagnosis of Myasthenia Gravis. Reviews the role and limitations of AChR antibody testing, repetitive nerve stimulation, SFEMG and bedside testing.

3. Vinciguerra C, et al. Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows. Reviews seronegative MG, MuSK and LRP4 antibodies, repetitive nerve stimulation and SFEMG.

4. NHS. Myasthenia gravis. Covers symptoms, specialist assessment and urgent help for severe breathing or swallowing difficulties.

5. Larner AJ, Thomas DJ. Can myasthenia gravis be diagnosed with the ice pack test? A cautionary note. Discusses the use and limitations of cooling in the assessment of myasthenic ptosis.

6. Jacob S, Farrugia ME, Hewamadduma C, et al. Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines — 2025 update. Practical Neurology. Current UK specialist guidance on MG management.

‍